0.51 USD
↘ 0.02 (3.73%)AT CLOSE (03:59 PM EST)
Coherus Oncology, Inc. Common Stock (CHRS) trades at $0.51 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CHRS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.